Bioavailability of Ration Items Containing Tart Cherry Extract
United States Army Research Institute of Environmental Medicine · NCT07063173
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 17–39 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 15
- US sites recruiting
- 1
- Study start
- June 14, 2024
- Record last updated
- December 29, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To determine how consuming food items containing shelf-stored tart cherry impacts your body's ability to absorb and use the compounds within tart cherry.
Being studied: Fruit Bar; Powdered Drink; Commercially available 100% tart cherry juice; Placebo beverage
Conditions: Bioavailability
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Active duty military personnel and civilians will be invited to participate in the study if they:
- Are between the ages of 18 (or 17 for military personnel) and 39.
- Are willing to participate in all study procedures and comply with all study instruction.
- In good health as determined by OMSO (Office of Medical Support and Oversight).
- Supervisor approval for federal civilian employees and non-HRV active-duty military personnel stationed at NSSC
Exclusion Criteria
- • Unable to understand verbal or written instructions or testing materials in English.
- Have a bleeding disorder (e.g., von Willebrand Disease, hemophilia) or are being treated with medication that will impair blood clotting (for example, coumadin)
- Have a history of GI-related conditions that may impact macronutrient absorption (e.g., Crohn's disease, ulcerative colitis, Celiac's disease or gluten sensitivity, bariatric surgery or gastroparesis, short bowel, inflammatory bowel disease, etc…);
- Any use of antibiotics or antifungal, except topical antibiotics/antifungals within 3 months of study participation.
- Colonoscopy within 3 months of study participation.
- Regular (i.e., weekly or more frequent) use of over-the-counter medications (including antacids, laxatives, stool softeners, and antidiarrheals) unless approved by OMSO and study PI.
- Are habitually taking nonsteroidal anti-inflammatory drugs (e.g., Advil, aspirin), corticosteroids (e.g., prednisone) or immunosuppressants (e.g. Humira);
- Have an allergy or aversion (extreme dislike) to any of the test foods(e.g., cherry flavored beverages or bar). Allergy symptoms may include anaphylaxis, hives or eczema, tingling/itching in the mouth, dizziness or fainting, diarrhea, nausea or vomiting, swelling of the lips, face, tongue and throat).
- Have donated blood within the past 8 weeks of the first test session or plan to donate blood during the study.
- Are not willing to abstain from tobacco products and vigorous exercise for at least 24 hours" before each trial and consume a low-polyphenol diet two days prior to each test session and on the day of the test session.
Recruiting US locations
USARIEM
Natick, MA 01760
Site contact: Tracey J Smith, PhD · 508-206-2390 · treacey.smith10.civ@health.mil
Study contacts (from the official record)
- Tracey J Smith, PhD · 5082062390 · tracey.smith10.civ@health.mil
- Robert Roussel, PhD · robert.r.roussel.civ@health.mil
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+